Valencia Nutrition (VALENCIA) | Stock Overview & Key Data
Valencia Nutrition Performance Comparison
Stock Range
Today's Range
Low: ₹68.82
High: ₹72.00
on August 11, 2025
52 Week Range
Low: ₹35.80
High: ₹72.00
on March 11, 2025
on August 11, 2025
All-Time High: ₹72.00 on August 11, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.2B
EPS
0.76
P/E Ratio (TTM)
90.55
Forward P/E
N/A
P/B Ratio
2.61
PEG Ratio
N/A
Div. Yield
N/A
ROE
6.22%
Beta
-0.106
Debt to Equity
4.06
Financial Highlights
Profitability
Gross Margin
-453.63%
Operating Margin
34.22%
Profit Margin
12.68%
Returns and Earnings
Return on Assets (TTM)
3.39%
Return on Equity (TTM)
6.22%
EBITDA
INR14.2M
Net Income (TTM)
INR10.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR4.99
Quarterly Revenue Growth (YoY)
902.50%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Valencia Nutrition VALENCIA | 1.17B Small-cap | 4.99% | 17.44% | 45.65% | 43.67% | 43.67% | 59.12% | 59.12% | 244.96% |
| Biocon BIOCON | 456.09B Large-cap | -10.38% | -7.04% | 2.62% | -8.96% | -6.90% | 1.90% | 10.35% | -13.10% |
| OneSource Specialty ONESOURCE | 216.76B Large-cap | 1.94% | -5.48% | 18.19% | 22.64% | 10.61% | 10.61% | 10.61% | 10.61% |
| Dishman Carbogen DCAL | 36.69B Small-cap | -3.47% | -8.84% | 27.79% | -2.26% | -17.23% | 22.14% | 106.15% | 27.13% |
| Zota Health Care ZOTA | 31.09B Small-cap | -0.78% | -2.36% | 45.12% | 25.14% | 50.88% | 85.82% | 335.52% | 755.41% |
| Panacea Biotec PANACEABIO | 25.12B Small-cap | 2.01% | 1.32% | -18.83% | 4.32% | -6.84% | 204.85% | 215.33% | 148.03% |
Ownership & Short Interest
Insider Ownership
61.67%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
16K
Average 90-Day Volume
16K
Valencia Nutrition Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Valencia Nutrition would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VALENCIA's 52-week high and low?
- In the last 52 weeks, Valencia Nutrition reached a high of ₹72.00 (on August 11, 2025) and a low of ₹35.80 (on March 11, 2025).
- What is the market cap and P/E ratio for VALENCIA?
- Curious about Valencia Nutrition's size and valuation? Its market capitalization stands at 1.17B. When it comes to valuation, the P/E ratio (trailing twelve months) is 90.55, and the forward P/E (looking ahead) is N/A.
- Does VALENCIA pay dividends? If so, what's the yield?
- As for dividends, Valencia Nutrition isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Valencia Nutrition's main competitors or similar companies to consider before investing?
When looking at Valencia Nutrition, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON456.09B Healthcare Biotechnology 1.90% 10.35% OneSource Specialty
ONESOURCE216.76B Healthcare Biotechnology 10.61% 10.61% Dishman Carbogen
DCAL36.69B Healthcare Biotechnology 22.14% 106.15% Zota Health Care
ZOTA31.09B Healthcare Biotechnology 85.82% 335.52% Panacea Biotec
PANACEABIO25.12B Healthcare Biotechnology 204.85% 215.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Valencia Nutrition Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Valencia Nutrition's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.22%, the Debt to Equity ratio from the most recent quarter is 4.06, and its Gross Profit Margin stands at -453.63%.
- What is the recent revenue and earnings growth for VALENCIA?
- Looking at Valencia Nutrition's growth, its revenue over the trailing twelve months (TTM) was INR85M. Compared to the same quarter last year (YoY), quarterly revenue grew by 902.50%, and quarterly earnings saw a YoY growth of N/A.
- How much of VALENCIA stock is held by insiders and institutions?
- Wondering who owns Valencia Nutrition stock? Company insiders (like executives and directors) hold about 61.67% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.